Memantine in behavioral variant frontotemporal dementia: negative results.

M, Vercelletto; C, Boutoleau-Bretonnière; C, Volteau; M, Puel; S, Auriacombe; M, Sarazin; BF, Michel; P, Couratier; C, Thomas-Antérion; P, Verpillat; A, Gabelle; V, Golfier; E, Cerato; L, Lacomblez

doi:10.3233/jad-2010-101632

Public

Memantine in behavioral variant frontotemporal dementia: negative results.

Shared by NobleBlocks on Jan 1, 2011 • 12:00 AM UTC

Authors:

Vercelletto M

Boutoleau-Bretonnière C

Volteau C

Abstract

We tested the efficacy and tolerability of one-year treatment with memantine (10 mg bid) in behavioral variant frontotemporal dementia (bvFTD). BvFTD patients aged 45 to 75 years, with a Mini-Mental Status Examination (MMSE) score ≥19, were enrolled in a national, randomized, double-blind, placebo-c...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!